![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 20, 2021 4:13:41 PM
What is the view here regarding the recent UK news of Antiviral purchase? does that eat market share from Lenz?
Lenz isn't in competition with antivirals. Lenz is an immunomodulator and doesn't have any antiviral properties. Lenz will always be used on patients who have already taken antivirals whether that be remdesivir, molnupiravir, or others. The best strategy is to give antivirals early. So far, the best data on antivirals is 50% efficacy. The patients who progress to the immunological stage of Covid and become hospitalized can then take lenzilumab.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM